Fate Therapeutics Inc
Change company Symbol lookup
Select an option...
FATE Fate Therapeutics Inc
WES Western Midstream Partners LP
BAC Bank of America Corp
UNH UnitedHealth Group Inc
MSFT Microsoft Corp
BWA BorgWarner Inc
PAC Grupo Aeroportuario del Pacifico SAB de CV
AAPL Apple Inc
SPH Suburban Propane Partners LP
PH Parker-Hannifin Corp

Health Care : Biotechnology | Small Cap Growth
Company profile

Fate Therapeutics, Inc. (Fate Therapeutics) is a clinical-stage biopharmaceutical company. The Company is engaged in development of programmed cellular immunotherapies for cancer and immune disorders. The Company's cell therapy pipeline consists of immuno-oncology programs, including cancer immunotherapies derived from engineered induced pluripotent cells, and immuno-regulatory programs, including hematopoietic cell immunotherapies for protecting the immune system of patients undergoing hematopoietic cell transplantation and for suppressing autoimmunity. Its lead clinical program is ProTmune, which is a programmed immuno-regulatory cell therapy. The Company programs immune cells, such as CD34+ cells, Natural Killer (NK) cells and T cells, by utilizing its cell programming approach. Its adoptive cell therapy programs are based on the Company's ex vivo cell programming approach, which it applies to modulate the therapeutic function and direct the fate of immune cells.


Last Trade
0.00 (0.00%)
B/A Size

Market Hours

Closing Price
Day's Change
0.41 (1.42%)
Bid close
Ask close
B/A Size
Day's High
Day's Low
(Heavy Day)

10-day average volume:

Here's why corporate debt investors may want to eye Ford's downgrade into 'junk'

3:16 pm ET September 10, 2019 (MarketWatch)

By Sunny Oh

Ford could become the fifth largest fallen angel in history


Moody's decision to downgrade Ford's debt to "junk" rating" (https://m.moodys.com/research/Moodys-downgrades-Ford-Credits-senior-rating-to-Ba1-with-a--PR_409719) sent alarm bells ringing among investors who have been jittery over the prospect of over-leveraged U.S. corporations losing their highly coveted investment-grade ratings.

But its their less creditworthy counterparts that may need to worry if Ford receives another downgrade by credit rating agencies S&P or Fitch and officially pushes the automaker out of investment-grade bond indexes. The sudden entry of a large issuer like Ford(F) into the high-yield bond market could weigh on prices for junk corporate credit.

The U.S. carmaker's more than $35 billion of debt would represent around 3% of the high-yield index. If one more credit ratings firm downgrades Ford, it would become the fifth biggest "fallen angel," or high-yield issuer once rated as investment-grade.

Analysts point to 2005 as a example of how fallen angels could overwhelm demand as investors struggle to absorb the bonds of the new entrant into the high-yield market.

Back then, troubles in the U.S. car industry saw both General Motors and Ford lose their investment-grade status. The junk bond market choked on the influx of supply as the total debt outstanding issued by both firms exceeded more than 12% of the overall market.

As a result, Marty Fridson, chief investment officer of Lehmann Livian Fridson Advisors, estimated (https://www.spglobal.com/marketintelligence/en/news-insights/latest-news-headlines/leveraged-loan-news/fridson-fallen-angel-watch-will-triple-b-downgrades-affect-high-yield-market)the downgrade of General Motors and its subsidiaries alone had caused high-yield credit spreads to widen by 50 points in 2005.

In other words, the extra premium investors demanded in return for owning a basket of junk bonds over comparable U.S. Treasurys had increased by another 50 basis points.

Investors have until now mostly focused on the $3 trillion worth of BBB-rated investment grade debt that is on the precipice of being downgraded to a junk rating, and may need to be sold by conservative investors like pension funds and insurance companies barred from holding debt from high-yield issuers.

But Hans Mikkelsen, head of U.S. investment grade bond strategy at Bank of America Merrill Lynch, said Ford's downgrade is more of an outlier in a largely improving story for the BBB-rated market.

"We think the Ford situation is idiosyncratic and has little read-through for the BBB-rated segment of the IG market where companies are less cyclical and using levers (cutting dividends, selling assets, etc.) to defend their IG ratings," said Mikkelsen.

See: Ford's debt rating gets downgraded to junk by Moody's (http://www.marketwatch.com/story/fords-debt-rating-gets-downgraded-to-junk-by-moodys-2019-09-09)

Opinion: The investing opportunity of a lifetime awaits us when the recession arrives (http://www.marketwatch.com/story/the-investing-opportunity-of-a-lifetime-awaits-us-when-the-recession-arrives-2019-08-20)

-Sunny Oh; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

September 10, 2019 15:16 ET (19:16 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.